Project Grant R03DE035161
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Ohio State University $690,195 under the Oral Diseases and Disorders Research program (CFDA 93.121) on March 1, 2026, for a five-year project extending through February 28, 2031. The project, "Neuroimmunology Regulating Reparative Dentinogenesis," will generate scientific knowledge regarding the cellular mechanisms that protect dental pulp tissue through immune and...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Ohio State University a $469,207 Project Grant (CFDA 93.121, Oral Diseases and Disorders Research) effective February 1, 2026 through January 31, 2028 to support basic research on pharmacological inhibition of ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) as a therapeutic strategy to promote cementum regeneration and restore periodontal attachment function. The research...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Ohio State University $1,397,346 under the Oral Diseases and Disorders Research program (CFDA 93.121) on August 11, 2025, for a mixed-methods research study examining silver diamine fluoride (SDF) treatment adoption and pediatric oral health outcomes. The five-year project (concluding May 31, 2030) will analyze national Medicaid claims data and conduct qualitative interviews with dentists...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Ohio State University a Project Grant of $393,750 on May 15, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the relationship between psychological stress, skeletal health, and immune function. The research will examine how repeated social defeat (RSD)—a validated murine model of psychosocial stress—induces bone loss and impairs bone growth plate...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of Toledo a Project Grant of $947,264 under the Oral Diseases and Disorders Research program (CFDA 93.121), effective May 1, 2025, through April 30, 2028. This three-year research initiative investigates IL-17 (Interleukin-17) receptor signaling in megakaryocytes and its role in oral mucosal immune responses during oropharyngeal candidiasis (OPC) caused by Candida albicans. The...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $310,295 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded on September 11, 2025, with a completion date of September 10, 2027. This research initiative aims to identify distinct subgroups of adolescents with chronic temporomandibular disorder (TMD) pain based on clinically relevant features...
- Federal Project Grant Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Cleveland Clinic Lerner College of Medicine of Case Western Reserve University a Project Grant totaling $568,759 under the Oral Diseases and Disorders Research program (CFDA 93.121) effective May 1, 2026 through April 30, 2031. This research initiative will deliver scientific investigation into pathogen synergy and immune subversion mechanisms in periodontal disease, specifically examining...
- Federal Project Grant Award Summary Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received an $885,500 Project Grant from the National Institute of Dental and Craniofacial Research under the Oral Diseases and Disorders Research program (CFDA 93.121) for the period August 14, 2025 through August 13, 2027. The award funds development of a pathomimetic gingiva-on-a-chip model designed to assess microbiota-directed anti-inflammatory therapeutics for periodontitis...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded $7.78 million to the University of Virginia under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop innovative pain management strategies for oral and head and neck cancer patients. Initiated September 1, 2025, and extending through August 31, 2029, this project addresses the clinical inadequacy of high-dose opioid analgesics by investigating succinate signaling through...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Oregon State University a $422,665 Project Grant on June 17, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop an integrated dental plaque bioanalytical platform for point-of-care diagnostics of oral diseases. The research addresses the significant financial burden of dental caries by creating a quantitative electrochemical biosensing platform capable...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Ohio State University a $315,000 Project Grant effective July 1, 2026, through June 30, 2028, under the Oral Diseases and Disorders Research program (CFDA 93.121). This research project will deliver two primary products: (1) improved characterization of cardiovascular autonomic nervous system (ANS) dysfunction phenotypes contributing to multisystem temporomandibular disorder (TMD) risk through analysis of longitudinal and cross-sectional data from the OPPERA (Orofacial Pain Prospective Evaluation and Risk Assessment) study, and (2) development and validation of a practical chairside symptom screening tool to identify high-risk individuals for TMD onset and persistence. The research addresses the clinical challenge that multisystem TMD—characterized by comorbid pain, anxiety, depression, and sleep disturbances—affects over 12 million U.S. adults and carries poor outcomes. The study leverages existing OPPERA datasets to characterize ANS dysfunction patterns at rest and during orthostatic stress, linking these patterns to symptom trajectories in multisystem TMD. The screening tool will incorporate multisystem symptoms and be validated for predictive validity in identifying at-risk populations. These deliverables are expected to provide novel mechanistic insights into ANS dysfunction in multisystem TMD and furnish clinicians with a practical early-identification resource, establishing a foundation for future pathophysiology-based intervention and prevention strategies for this prevalent condition.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $315.0k | 6/23/26 |